Enanta Pharmaceuticals
ENTA
#7695
Rank
A$0.63 B
Marketcap
A$21.79
Share price
2.30%
Change (1 day)
86.63%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2025 (TTM): -A$0.12 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are A$65.32 Million. In 2024 the company made an earning of -A$0.14 Billion, an increase over its 2023 earnings that were of -A$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.12 Billion-15.05%
2024 -A$0.14 Billion-23.87%
2023 -A$0.19 Billion4.39%
2022 -A$0.18 Billion-4.4%
2021 -A$0.19 Billion91.12%
2020 -A$96.36 Million-407.13%
2019 A$31.37 M-78.63%
2018 A$0.14 B117.97%
2017 A$67.35 M-574.65%
2016 -A$14.2 Million-110.83%
2015 A$0.13 B-4.5%
2014 A$0.13 B-638.53%
2013 -A$25.49 Million-137.98%
2012 A$67.09 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.46 B-34,342.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.76 B-20,904.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
A$9.51 B-8,795.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$7.30 B-6,771.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$18.96 B-17,435.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.84 B-12,749.60%๐Ÿ‡บ๐Ÿ‡ธ USA